| Literature DB >> 33522708 |
Fatemeh Namazi1, Azizollah Khodakaram Tafti1.
Abstract
Lumpy skin disease is an emerging bovine viral disease, which is endemic in most African countries and some Middle East ones, and the elevated risk of the spread of disease into the rest of Asia and Europe should be considered. The recent rapid spread of disease in currently disease-free countries indicates the importance of understanding the limitations and routes of distribution. The causative agent, Capripoxvirus, can also induce sheeppox and goatpox. The economic significance of these diseases is of great concern, given that they threaten international trade and could be used as economic bioterrorism agents. The distribution of capripoxviruses seems to be expanding due to limited access to effective vaccines and poverty within farming communities. This is largely due to the economic effects of the Covid-19 pandemic and the imposition of crippling sanctions in endemic regions, as well as an increase in the legal and illegal trade of live animals and animal products, and also global climate change. The present review is designed to provide existing information on the various aspects of the disease such as its clinicopathology, transmission, epidemiology, diagnosis, prevention and control measures, and the potential role of wildlife in the further spread of disease.Entities:
Keywords: capripox; epidemiology; lumpy skin disease; transboundary disease
Mesh:
Year: 2021 PMID: 33522708 PMCID: PMC8136940 DOI: 10.1002/vms3.434
Source DB: PubMed Journal: Vet Med Sci ISSN: 2053-1095
FIGURE 1Lumpy skin disease. Raised, circumscripted nodular lesions
FIGURE 2Global situation of lumpy skin disease (FAO, 2016)
FIGURE 3The number of LSD outbreaks in different countries during 2014–2016 (OIE, 2018)
Different techniques for LSD diagnosis
| Techniques | Purposes | |||||
|---|---|---|---|---|---|---|
| Animals freedom from infection | Animal freedom from infection previous to movement | Contribution in eradication policies | Confirmation of clinical cases | Prevalence of infection surveillance | Immune status post‐vaccination | |
| Identification of agent | ||||||
| Virus isolation | + | ++ | + | +++ | + | ‐ |
| PCR | ++ | +++ | ++ | +++ | + | ‐ |
| Electron microscopy | ‐ | ‐ | ‐ | + | ‐ | ‐ |
| Immune response detection | ||||||
| Virus neutralization | ++ | ++ | ++ | ++ | ++ | ++ |
| Electron microscopy | + | + | + | + | + | + |
−: not appropriate for the purpose; +: may be used in some situations, but its application is limited by some factors such as reliability, cost, etc.; ++: appropriate method; +++: recommended method.
IFAT indicates Indirect Fluorescent Antibody Test; and PCR, polymerase chain reaction.